500 related articles for article (PubMed ID: 7521347)
1. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).
Tamai H; Mukuta T; Matsubayashi S; Fukata S; Komaki G; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1993 Nov; 77(5):1356-60. PubMed ID: 7521347
[TBL] [Abstract][Full Text] [Related]
2. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report.
Chien MN; Wang CH; Tsan KW
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):351-5. PubMed ID: 8605651
[TBL] [Abstract][Full Text] [Related]
3. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Magner JA; Snyder DK
Thyroid; 1994; 4(3):295-6. PubMed ID: 7530522
[TBL] [Abstract][Full Text] [Related]
4. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Murakami N
Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
8. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
9. Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).
Willfort A; Lorber C; Kapiotis S; Sertl S; Hainz R; Kirchweger P; Jäger U; Kyrle PA; Lechner K; Geissler K
Ann Hematol; 1993 May; 66(5):241-4. PubMed ID: 7685193
[TBL] [Abstract][Full Text] [Related]
10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
11. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
Góra-Tybor J; Krykowski E; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study.
Fukata S; Kuma K; Sugawara M
Thyroid; 1999 Jan; 9(1):29-31. PubMed ID: 10037073
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
Somogyi A; Werling K; Rosta A; Láng I
Orv Hetil; 1994 Nov; 135(45):2483-5. PubMed ID: 7991239
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis.
Murakami Y; Sasaki I; Hiraiwa T; Arishima T; Ito M; Hanafusa T; Sakane S; Ohsawa N; Takamatsu J; Miyauchi A; Kuma K
Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577
[TBL] [Abstract][Full Text] [Related]
16. Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere.
Hirsch D; Luboshitz J; Blum I
Thyroid; 1999 Oct; 9(10):1033-5. PubMed ID: 10560960
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis.
Endo S; Inada K; Inoue Y; Yamada Y; Takakuwa T; Kasai T; Nakae H; Kuwata Y; Hoshi S; Yashida M
Curr Med Res Opin; 1994; 13(4):233-41. PubMed ID: 7533691
[TBL] [Abstract][Full Text] [Related]
18. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor.
Somogyi A; Rosta A; Lang I; Werling K
Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
[TBL] [Abstract][Full Text] [Related]
20. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
